PLSE
Pulse Biosciences, Inc.$55.41+1.21 (+2.22%)Prev Close$54.21·MCap$3.68B·P/E—·Vol344.5K·Yield—
▲
Buys (12M)
4
$13.50M
▼
Sells (12M)
6
$4.13M
◆
Net Activity
Net Buyer
$9.37M
●
Active Insiders
5
last 12 mo
Over the past 12 months, insider activity at Pulse Biosciences, Inc. (PLSE) has been dominated by buying, with 4 insider purchases totaling $13.50M and 6 insider sales totaling $4.13M. The most recent insider transaction was by Teplitsky Liane Rae (officer: Chief Operating Officer), who purchased $100.0K worth of shares on Sep 2, 2026. Pulse Biosciences, Inc. operates in the Healthcare sector, within the Medical - Instruments & Supplies industry, with a market cap of $3.68B.
PLSE Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Teplitsky Liane Rae | officer: Chief Operating Officer | Buy | 2,025 | $49.37 | $100.0K | 4,095+98% |
| Aug 28, 2026 | Teplitsky Liane Rae | officer: Chief Operating Officer | Buy | 2,070 | $48.29 | $100.0K | 2,070 |
| May 11, 2026 | DUGGAN ROBERT W | director, 10 percent owner: | Buy | 660,233 | $19.69 | $13.00M1.0% OS | 48,211,432 |
| May 11, 2026 | LAVIOLETTE PAUL A | director, officer: Chief Executive Officer | Buy | 15,000 | $19.69 | $295.4K | 15,000 |
| Feb 18, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Sell | 5,000 | $23.64 | $118.2K | 0 |
| Feb 12, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Sell | 60,000 | $23.51 | $1.41M | 0 |
| Feb 11, 2026 | Danahy Kevin Patrick | officer: Chief Commercial Officer | Sell | 60,000 | $23.39 | $1.40M | 43,298-58% |
| Oct 7, 2025 | Danahy Kevin Patrick | Chief Commercial Officer | Sell | 4,600 | $18.53 | $85.2K | 43,298 |
| Sep 22, 2025 | Danahy Kevin Patrick | Chief Commercial Officer | Sell | 20,400 | $18.49 | $377.2K | 43,298-32% |
| Sep 18, 2025 | UECKER DARRIN | Chief Technology Officer | Sell | 45,000 | $16.25 | $731.2K | 122,872-27% |
| Sep 15, 2025 | UECKER DARRIN | Chief Technology Officer | Sell | 75,000 | $14.96 | $1.12M | 122,872-38% |
| Sep 12, 2025 | DUGGAN ROBERT W | Director | Buy | 192,599 | $14.48 | $2.79M | 47,709,140 |
| Jun 16, 2025 | UECKER DARRIN | Chief Technology Officer | Sell | 30,000 | $16.19 | $485.7K | 137,872 |
| Dec 20, 2024 | Barrett Burke Thomas | Sell | 50,000 | $17.42 | $871.0K | 63,172-44% | |
| Dec 17, 2024 | DUGGAN ROBERT W | Director | Buy | 100,660 | $17.16 | $1.73M | 42,328,716 |
| Dec 13, 2024 | DUGGAN ROBERT W | Director | Buy | 56,054 | $17.35 | $972.3K | 42,228,056 |
| May 22, 2024 | Barrett Burke Thomas | President and CEO | Buy | 10,000 | $8.56 | $85.6K | 10,000 |
| Dec 14, 2023 | DUGGAN ROBERT W | Director | Buy | 17,999 | $9.15 | $164.7K | 36,984,180 |
| Dec 13, 2023 | DUGGAN ROBERT W | Director | Buy | 90,118 | $9.36 | $843.5K | 36,966,180 |
| Dec 12, 2023 | DUGGAN ROBERT W | Director | Buy | 116,656 | $9.54 | $1.11M | 36,876,064 |
| Dec 11, 2023 | DUGGAN ROBERT W | Director | Buy | 74,852 | $9.19 | $687.9K | 36,759,408 |
| Dec 8, 2023 | DUGGAN ROBERT W | Director | Buy | 82,813 | $9.06 | $750.3K | 36,684,552 |
| Dec 7, 2023 | DUGGAN ROBERT W | Director | Buy | 66,021 | $9.34 | $616.6K | 351,565 |
| Dec 6, 2023 | DUGGAN ROBERT W | Director | Buy | 27,000 | $10.38 | $280.3K | 285,544 |
| Dec 5, 2023 | DUGGAN ROBERT W | Director | Buy | 45,600 | $9.07 | $413.6K | 258,544 |
| Dec 4, 2023 | DUGGAN ROBERT W | Director | Buy | 152,944 | $9.06 | $1.39M | 212,944+255% |
| Dec 1, 2023 | DUGGAN ROBERT W | Director | Buy | 218,600 | $9.38 | $2.05M | 36,551,460 |
| Nov 30, 2023 | DUGGAN ROBERT W | Director | Buy | 124,397 | $8.98 | $1.12M | 36,391,192 |
| Nov 20, 2023 | DUGGAN ROBERT W | Director | Buy | 20,241 | $6.10 | $123.5K | 36,266,796 |
| Nov 17, 2023 | Danahy Kevin Patrick | Chief Executive Officer | Buy | 5,393 | $6.52 | $35.2K | 35,887 |
| Nov 17, 2023 | Levinson Mitchell E. | Chief Strategy Officer | Buy | 17,800 | $5.90 | $105.1K | 73,027+32% |
| May 10, 2023 | DUGGAN ROBERT W | Director | Buy | 10,022,937 | $6.51 | $65.25M14.7% OS | 30,414,660+49% |
| Oct 11, 2022 | Levinson Mitchell E. | Chief Strategy Officer | Buy | 30,780 | $2.27 | $69.9K | 46,274+199% |
| Oct 3, 2022 | Danahy Kevin Patrick | Chief Executive Officer | Buy | 6,500 | $2.30 | $14.9K | 6,500 |
| Jul 2, 2021 | DUGGAN ROBERT W | Director | Buy | 3,048,780 | $16.40 | $50.00M4.5% OS | 14,708,561+26% |
PLSE Insider Buying Activity
The following table shows recent insider purchases of Pulse Biosciences, Inc. (PLSE) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Teplitsky Liane Rae | officer: Chief Operating Officer | Buy | 2,025 | $49.37 | $100.0K | 4,095+98% |
| Aug 28, 2026 | Teplitsky Liane Rae | officer: Chief Operating Officer | Buy | 2,070 | $48.29 | $100.0K | 2,070 |
| May 11, 2026 | DUGGAN ROBERT W | director, 10 percent owner: | Buy | 660,233 | $19.69 | $13.00M1.0% OS | 48,211,432 |
| May 11, 2026 | LAVIOLETTE PAUL A | director, officer: Chief Executive Officer | Buy | 15,000 | $19.69 | $295.4K | 15,000 |
| Sep 12, 2025 | DUGGAN ROBERT W | Director | Buy | 192,599 | $14.48 | $2.79M | 47,709,140 |
| Dec 17, 2024 | DUGGAN ROBERT W | Director | Buy | 100,660 | $17.16 | $1.73M | 42,328,716 |
| Dec 13, 2024 | DUGGAN ROBERT W | Director | Buy | 56,054 | $17.35 | $972.3K | 42,228,056 |
| May 22, 2024 | Barrett Burke Thomas | President and CEO | Buy | 10,000 | $8.56 | $85.6K | 10,000 |
| Dec 14, 2023 | DUGGAN ROBERT W | Director | Buy | 17,999 | $9.15 | $164.7K | 36,984,180 |
| Dec 13, 2023 | DUGGAN ROBERT W | Director | Buy | 90,118 | $9.36 | $843.5K | 36,966,180 |
| Dec 12, 2023 | DUGGAN ROBERT W | Director | Buy | 116,656 | $9.54 | $1.11M | 36,876,064 |
| Dec 11, 2023 | DUGGAN ROBERT W | Director | Buy | 74,852 | $9.19 | $687.9K | 36,759,408 |
| Dec 8, 2023 | DUGGAN ROBERT W | Director | Buy | 82,813 | $9.06 | $750.3K | 36,684,552 |
| Dec 7, 2023 | DUGGAN ROBERT W | Director | Buy | 66,021 | $9.34 | $616.6K | 351,565 |
| Dec 6, 2023 | DUGGAN ROBERT W | Director | Buy | 27,000 | $10.38 | $280.3K | 285,544 |
| Dec 5, 2023 | DUGGAN ROBERT W | Director | Buy | 45,600 | $9.07 | $413.6K | 258,544 |
| Dec 4, 2023 | DUGGAN ROBERT W | Director | Buy | 152,944 | $9.06 | $1.39M | 212,944+255% |
| Dec 1, 2023 | DUGGAN ROBERT W | Director | Buy | 218,600 | $9.38 | $2.05M | 36,551,460 |
| Nov 30, 2023 | DUGGAN ROBERT W | Director | Buy | 124,397 | $8.98 | $1.12M | 36,391,192 |
| Nov 20, 2023 | DUGGAN ROBERT W | Director | Buy | 20,241 | $6.10 | $123.5K | 36,266,796 |
| Nov 17, 2023 | Danahy Kevin Patrick | Chief Executive Officer | Buy | 5,393 | $6.52 | $35.2K | 35,887 |
| Nov 17, 2023 | Levinson Mitchell E. | Chief Strategy Officer | Buy | 17,800 | $5.90 | $105.1K | 73,027+32% |
| May 10, 2023 | DUGGAN ROBERT W | Director | Buy | 10,022,937 | $6.51 | $65.25M14.7% OS | 30,414,660+49% |
| Oct 11, 2022 | Levinson Mitchell E. | Chief Strategy Officer | Buy | 30,780 | $2.27 | $69.9K | 46,274+199% |
| Oct 3, 2022 | Danahy Kevin Patrick | Chief Executive Officer | Buy | 6,500 | $2.30 | $14.9K | 6,500 |
| Jul 2, 2021 | DUGGAN ROBERT W | Director | Buy | 3,048,780 | $16.40 | $50.00M4.5% OS | 14,708,561+26% |
PLSE Insider Selling Activity
The following table shows recent insider sales of Pulse Biosciences, Inc. (PLSE) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Sell | 5,000 | $23.64 | $118.2K | 0 |
| Feb 12, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Sell | 60,000 | $23.51 | $1.41M | 0 |
| Feb 11, 2026 | Danahy Kevin Patrick | officer: Chief Commercial Officer | Sell | 60,000 | $23.39 | $1.40M | 43,298-58% |
| Oct 7, 2025 | Danahy Kevin Patrick | Chief Commercial Officer | Sell | 4,600 | $18.53 | $85.2K | 43,298 |
| Sep 22, 2025 | Danahy Kevin Patrick | Chief Commercial Officer | Sell | 20,400 | $18.49 | $377.2K | 43,298-32% |
| Sep 18, 2025 | UECKER DARRIN | Chief Technology Officer | Sell | 45,000 | $16.25 | $731.2K | 122,872-27% |
| Sep 15, 2025 | UECKER DARRIN | Chief Technology Officer | Sell | 75,000 | $14.96 | $1.12M | 122,872-38% |
| Jun 16, 2025 | UECKER DARRIN | Chief Technology Officer | Sell | 30,000 | $16.19 | $485.7K | 137,872 |
| Dec 20, 2024 | Barrett Burke Thomas | Sell | 50,000 | $17.42 | $871.0K | 63,172-44% |
PLSE Insiders
Danahy Kevin Patrick
officer: Chief Commercial Officer
Bought $50.1KSold $3.39M
7 tradesLast: Feb 18, 2026
Similar Stocks to PLSE
ISRG
Intuitive Surgical, Inc.
$377.14-0.20%
$124.79B
BDX
Becton, Dickinson and Company
$185.69+1.52%
$49.54B
RMD
ResMed Inc.
$230.54+3.39%
$31.91B
WST
West Pharmaceutical Services, Inc.
$362.89+2.17%
$24.37B
COO
The Cooper Companies, Inc.
$53.36-1.59%
$10.51B
RGEN
Repligen Corporation
$174.91+4.11%
$9.32B
ATR
AptarGroup, Inc.
$124.14-0.61%
$7.97B
MMSI
Merit Medical Systems, Inc.
$86.14-1.01%
$5.35B